Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 11 trials

Success Rate

100.0%

+13.4% vs industry average

Late-Stage Pipeline

36%

4 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

8 recruiting

Enrollment Performance

Analytics

N/A
4(50.0%)
Phase 4
4(50.0%)
8Total
N/A(4)
Phase 4(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (11)

Showing 11 of 11 trials
NCT07665268Phase 4Recruiting

Study Title: A Multicenter, Prospective, Modified Platform Trial Evaluating Several Cellular, Acellular, and Matrix-like Products (CAMPs) and Standard of Care Versus Matched Standard of Care Controls in the Management of Nonhealing Pressure Ulcers.

Role: collaborator

NCT07086443Phase 4Recruiting

Randomized Evaluation of Nonhealing Diabetic Foot Ulcers With Exclusive Wound Therapy

Role: collaborator

NCT07360418Recruiting

Evaluating the Durability of Closure for Diabetic Foot Ulcers Following a Randomized, Controlled, Modified Platform Trial.

Role: collaborator

NCT07364630Phase 4Recruiting

A Multicenter, Prospective, Controlled Modified Multi-Platform Trial Assessing the Efficacy of Human Placental Membrane Products and Standard of Care in the Management of Nonhealing Diabetic Foot Ulcers and Venous Leg Ulcers.

Role: collaborator

NCT07219004Not ApplicableCompleted

Artacent Amniotic Tissue for Treatment of Chronic Lower Extremity Diabetic Ulcers.

Role: collaborator

NCT06782386Not ApplicableActive Not Recruiting

Remote Temperature and Visual Monitoring To Help Manage Diabetic Foot Ulcers

Role: collaborator

NCT06437028Not ApplicableRecruiting

Evaluating the Efficacy of Perinatal Membrane Allografts in Addition to the Standard of Care for the Treatment of Non-healing Diabetic Foot Ulcers.

Role: collaborator

NCT06618612Not ApplicableRecruiting

A Study to Evaluate the Efficacy of a Purified Native Type 1 Collagen Extracellular Matrix With Polyhexamethylene Biguanide Antimicrobial (PCMP) and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot Ulcers

Role: collaborator

NCT06697925Recruiting

Evaluating the Durability of Closure for Venous Leg Ulcers

Role: collaborator

NCT06693570Phase 4Recruiting

Evaluating Intact Fish Skin Graft and Standard of Care Versus Standard of Care Alone in Nonhealing Venous Leg Ulcers

Role: collaborator

NCT04630704Unknown

Evaluating A Non-Invasive Tissue Perfusion Monitor

Role: collaborator

All 11 trials loaded